Animal health firm SeQuent Scientific appoints Rajaram Narayanan as new CEO

SeQuent Scientific, an Indian animal health company, has appointed Rajaram Narayanan as the company’s new managing director (MD) and CEO, effective from 11 April 2022.

Rajaram Narayanan is said to have worked in senior leadership roles in the pharmaceutical, consumer goods, and services industries. He will take over from Manish Gupta, who will move away from the posts of MD and CEO effective 10 April 2022 after being in the roles for the last eight years.

Manish Gupta will continue to be a strategic advisor to SeQuent Scientific until July 2022.

Dr. Kamal K Sharma — Non-Executive Chairman of SeQuent Scientific said: “We are delighted to welcome Rajaram as MD and CEO of SeQuent as he has a solid track record of successfully transforming businesses in highly complex and regulated industries.

“His strategic vision as well as operational expertise and rigor will be pivotal for the company’s next phase of growth and success, and the Board of Directors looks forward to working with him.”

Backed by global investment firm Carlyle, SeQuent Scientific is focused currently on implementing its SeQuent 2.0 growth strategy. For this, the company aims to scale its footprint in existing markets, grow into new international markets, and expedite research and development in animal health active pharmaceutical ingredients (APIs) and formulations, including value-added generics.

Rajaram Narayanan is expected to oversee the next phase of growth and expansion for the Indian animal health company. He comes from Sanofi India where he served as the MD and Country Chair for India.

Rajaram Narayanan said: “I am honoured to join SeQuent, particularly at a time when the global animal healthcare industry is growing at a significant pace due to increased demand for quality livestock and food safety, and a rise in adoption of companion animals.

“As one of the leading animal healthcare companies globally, SeQuent is uniquely positioned to seize these market opportunities, and I am excited to lead the company through its next phase of development.”